bibliographic entry 6949440 [be/6949440]
https://w3id.org/oc/corpus/be/6949440

is a

• bibliographic reference

content

• U.S. Food and Drug Administration. Saxagliptin (marketed as Onglyza and Kombiglyze XR): drug safety communication -FDA to review heart failure risk. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm385471.htm (accessed August 27 2015).

references

• https://w3id.org/oc/corpus/br/1720926